SCN5A was more highly expressed in tumor samples from patients who subsequently developed metastases than from those who did not within 1 year (P < 0.05), 3 years (P < 0.01), and 5 years (P < 0.01) [43]. The gene discussed is SCN5A; the disease is neoplasm.